Hydrophilic Polymer-Based Matrix Tablets for Extended Release of Metoprolol succinate: Formulation Strategies, Polymer Selection, Optimization, and Evaluation-A Review

Abstract

Metoprolol succinate is a cardioselective β1-adrenergic receptor blocker extensively prescribed for the management of hypertension, angina pectoris, arrhythmias, heart failure, and other cardiovascular disorders. Despite its wide therapeutic use, conventional immediate-release formulations require frequent administration due to relatively short biological half-life and variable plasma concentration profiles, which may result in fluctuations in therapeutic response and reduced patient compliance. Extended-release oral dosage forms have therefore attracted significant pharmaceutical interest because they offer sustained drug release, reduced dosing frequency, improved plasma concentration maintenance, minimized side effects, and enhanced patient adherence. Among various controlled-release technologies, hydrophilic polymerbased matrix tablets remain one of the most widely employed and commercially successful platforms because of their formulation simplicity, cost-effectiveness, scalability, and reliable release modulation characteristics. Hydrophilic polymers such as hydroxypropyl methylcellulose (HPMC), polyethylene oxide (PEO), sodium carboxymethyl cellulose, xanthan gum, and carbopol hydrate upon contact with gastrointestinal fluids, forming a gel barrier that regulates drug diffusion and matrix erosion. The interplay between polymer viscosity, swelling index, hydration rate, tablet porosity, and polymer concentration significantly influences release kinetics and overall dosageperformance. This review critically summarizes the pharmaceutical rationale for extended-release matrix tablets of Metoprolol succinate, discusses commonly employed hydrophilic polymers, formulation design strategies, optimization approaches, drug release mechanisms, and evaluation parameters. Special emphasis is placed on polymer selection, matrix integrity, kinetic modeling, and recent advances in smart hydrophilic polymer systems for sustained cardiovascular drug delivery.